Five Prime Therapeutics, Inc.
|
Q3 2019
Filed on Nov 15, 2019
|
547,712
|
N/A
|
|
|
Q3 2019
Filed on Nov 15, 2019
|
200,000
|
$37.38 - $49.47
$7.48M - $9.89M
|
|
|
Q3 2019
Filed on Nov 15, 2019
|
926,933
|
$2.8 - $3.99
$2.6M - $3.7M
|
|
|
Q3 2019
Filed on Nov 15, 2019
|
2,211,194
|
N/A
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
200,000
|
$35.13 - $55.53
$7.03M - $11.1M
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
400,000
|
$77.77 - $120.68
$31.1M - $48.3M
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
660,366
|
$2.37 - $11.7
$1.57M - $7.73M
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
5,955,762
|
$2.91 - $9.15
$17.3M - $54.5M
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
200,000
|
$4.6 - $10.13
$920K - $2.03M
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
200,000
|
N/A
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
2,000,000
|
N/A
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
1,800,000
|
N/A
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
492,100
|
$27.2 - $41.2
$13.4M - $20.3M
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
2,173,913
|
$11.43 - $15.12
$24.8M - $32.9M
|
|
Sunesis Pharmaceuticals Inc
|
Q1 2019
Filed on May 14, 2019
|
317,962
|
N/A
|
|
|
Q1 2019
Filed on May 14, 2019
|
40,197
|
$72.76 - $93.45
$2.92M - $3.76M
|
|
|
Q1 2019
Filed on May 14, 2019
|
18,500
|
$98.85 - $134.59
$1.83M - $2.49M
|
|
|
Q1 2019
Filed on May 14, 2019
|
664,681
|
N/A
|
|
|
Q1 2019
Filed on May 14, 2019
|
630,600
|
N/A
|
|
|
Q1 2019
Filed on May 14, 2019
|
143,481
|
$69.08 - $105.66
$9.91M - $15.2M
|
|
|
Q1 2019
Filed on May 14, 2019
|
400,000
|
$10.9 - $14.09
$4.36M - $5.64M
|
|
|
Q1 2019
Filed on May 14, 2019
|
26,000
|
$89.33 - $163.65
$2.32M - $4.25M
|
|
|
Q1 2019
Filed on May 14, 2019
|
955,618
|
$6.5 - $13.77
$6.21M - $13.2M
|
|
|
Q1 2019
Filed on May 14, 2019
|
200,000
|
$163.73 - $194.7
$32.7M - $38.9M
|
|
|
Q4 2018
Filed on Feb 15, 2019
|
490,843
|
N/A
|
|
|
Q4 2018
Filed on Feb 15, 2019
|
1,606,100
|
N/A
|
|
|
Q4 2018
Filed on Feb 15, 2019
|
21,441
|
$0.73 - $2.19
$15.7K - $47K
|
|
|
Q4 2018
Filed on Feb 15, 2019
|
58,461
|
$16.55 - $30.22
$968K - $1.77M
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
1,596,200
|
$2.45 - $16.27
$3.91M - $26M
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
713,998
|
$32.0 - $52.4
$22.8M - $37.4M
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
1,056,825
|
$2.45 - $16.27
$2.59M - $17.2M
|
|
Novelion Therapeutics Inc
|
Q3 2018
Filed on Nov 14, 2018
|
2,500
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
200,000
|
$38.0 - $51.1
$7.6M - $10.2M
|
|
Achillion Pharmaceuticals Inc
|
Q3 2018
Filed on Nov 14, 2018
|
2,988,716
|
N/A
|
|
Corsicanto Ii Designated Act
|
Q3 2018
Filed on Nov 14, 2018
|
10,000,000
|
N/A
|
|
Alexion Pharmaceuticals Inc
|
Q3 2018
Filed on Nov 14, 2018
|
110,506
|
N/A
|
|
Celldex Therapeutics Inc New
|
Q3 2018
Filed on Nov 14, 2018
|
804,483
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
759,494
|
$3.0 - $4.05
$2.28M - $3.08M
|
|
|
Q2 2018
Filed on Aug 14, 2018
|
233,500
|
N/A
|
|
|
Q2 2018
Filed on Aug 14, 2018
|
2,695,742
|
$2.26 - $3.84
$6.09M - $10.4M
|
|
|
Q2 2018
Filed on Aug 14, 2018
|
500,000
|
$10.99 - $44.21
$5.5M - $22.1M
|
|
|
Q2 2018
Filed on Aug 14, 2018
|
900,579
|
N/A
|
|
|
Q2 2018
Filed on Aug 14, 2018
|
309,800
|
$13.95 - $19.15
$4.32M - $5.93M
|
|
|
Q2 2018
Filed on Aug 14, 2018
|
500,000
|
N/A
|
|
|
Q1 2018
Filed on May 14, 2018
|
800,000
|
$4.0 - $8.15
$3.2M - $6.52M
|
|
|
Q1 2018
Filed on May 14, 2018
|
300,000
|
$29.15 - $37.4
$8.75M - $11.2M
|
|
|
Q1 2018
Filed on May 14, 2018
|
4,127,232
|
N/A
|
|
|
Q1 2018
Filed on May 14, 2018
|
669,472
|
$19.24 - $28.03
$12.9M - $18.8M
|
|
|
Q1 2018
Filed on May 14, 2018
|
331,085
|
$32.45 - $54.7
$10.7M - $18.1M
|
|
|
Q1 2018
Filed on May 14, 2018
|
2,850,000
|
N/A
|
|